The ADC binds HER2 on tumor cells, is internalized, and releases MMAE, which binds tubulin to inhibit microtubule polymerization, causing G2/M arrest and apoptosis (with possible bystander effect and Fc-mediated ADCC). Tubulin itself is not the antigen targeted by the drug.